The Efficacy of a Mix of Probiotics (<i>Limosilactobacillus reuteri</i> LMG P-27481 and <i>Lacticaseibacillus rhamnosus</i> GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and <i>Clostridium difficile</i> Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial

The Efficacy of a Mix of Probiotics (<i>Limosilactobacillus reuteri</i> LMG P-27481 and <i>Lacticaseibacillus rhamnosus</i> GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and <i>Clostridium difficile</i> Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial

Background: Antibiotic-associated diarrhea is a condition reported in 5–35% of patients treated with antibiotics, especially in older patients with comorbidities. In most cases, antibiotic-associated diarrhea is not associated with serious complications, but it can prolong hospitalization and provok...

Full description

Bibliographic Details
Main Authors: Angela Saviano, Carmine Petruzziello, Clelia Cancro, Noemi Macerola, Anna Petti, Eugenia Nuzzo, Alessio Migneco, Veronica Ojetti
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Microorganisms
Subjects:
<i>Limosilactobacillus reuteri</i> LMG P-27481
<i>Lacticaseibacillus rhamnosus</i> GG ATCC 53103
probiotic
antibiotic
diarrhea
Online Access:https://www.mdpi.com/2076-2607/12/1/198

Internet

https://www.mdpi.com/2076-2607/12/1/198

Similar Items